CHICAGO--(EON: Enhanced Online News)--Global professional services firm Huron (NASDAQ: HURN) today announced that it has expanded its life sciences strategy expertise with the acquisition of Pope Woodhead & Associates. The UK-based consulting firm provides market access capabilities to assist clients in developing value propositions for innovative medicines and technologies. The acquisition strengthens the firm’s ability to lead clients through complex payer and regulatory environments across the global healthcare community.
“Huron and Pope Woodhead’s combined strategic capabilities, market access expertise, deep industry knowledge and global presence enhance our ability to help clients tackle their most pressing problems and deliver measurable results.”
“Life sciences companies are facing tough economic and regulatory environments and are under increasing pressure to justify the value of their innovations to consumers, payers and policymakers,” said James H. Roth, chief executive officer and president of Huron. “Huron and Pope Woodhead’s combined strategic capabilities, market access expertise, deep industry knowledge and global presence enhance our ability to help clients tackle their most pressing problems and deliver measurable results.”
Pope Woodhead, based in Cambridge, England, partners with the top global pharmaceutical companies as well as biotech and medical device organizations to bring to market therapies that improve patients’ health. The firm’s knowledge of global, regional and local markets and deep understanding of the value of their clients’ innovations have made them a preferred partner of many life sciences organizations.
“Huron is a natural fit for our clients and our employees,” said Andrew Hobbs, chief executive officer of Pope Woodhead, who now becomes a Huron managing director. “Together we will help clients solve their most complex problems by applying our combined expertise to create successful pricing, reimbursement, safety and regulatory strategies.”
For reporting purposes, Pope Woodhead will be included in Huron’s Education and Life Sciences operating segment. Terms of the stock purchase transaction were not disclosed.
Huron is a global professional services firm committed to achieving sustainable results in partnership with its clients. The company brings depth of expertise in strategy, technology, operations, advisory services and analytics to drive lasting and measurable results in the healthcare, higher education, life sciences and commercial sectors. Through focus, passion and collaboration, Huron provides guidance to support organizations as they contend with the change transforming their industries and businesses. Learn more at www.huronconsultinggroup.com.
Statements in this press release that are not historical in nature, including those concerning the Company’s current expectations about its future requirements and needs, are “forward-looking” statements as defined in Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by words such as “may,” “should,” “expects,” “provides,” “anticipates,” “assumes,” “can,” “will,” “meets,” “could,” “likely,” “intends,” “might,” “predicts,” “seeks,” “would,” “believes,” “estimates,” “plans,” “continues,” or “outlook” or similar expressions. These forward-looking statements reflect our current expectations about our future requirements and needs, results, levels of activity, performance, or achievements. Some of the factors that could cause actual results to differ materially from the forward-looking statements contained herein include, without limitation: failure to achieve expected utilization rates, billing rates and the number of revenue-generating professionals; inability to expand or adjust our service offerings in response to market demands; our dependence on renewal of client-based services; dependence on new business and retention of current clients and qualified personnel; failure to maintain third-party provider relationships and strategic alliances; inability to license technology to and from third parties; the impairment of goodwill; various factors related to income and other taxes; difficulties in successfully integrating the businesses we acquire and achieving expected benefits from such acquisitions; risks relating to privacy, information security, and related laws and standards; and a general downturn in market conditions. These forward-looking statements involve known and unknown risks, uncertainties, and other factors, including, among others, those described under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2015, that may cause actual results, levels of activity, performance or achievements to be materially different from any anticipated results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. We disclaim any obligation to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.